Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid vs Physical Activity for Bone Density in Breast Cancer
NCT00202059Phase 3Completed
- Sponsor
- HealthPartners Institute
- Start
- Jun 2003
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in osteopenia, osteoporosis, sponsored by HealthPartners Institute. Started Jun 2003; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteopeniaosteoporosis
Beyond the preview
Go deeper on NCT00202059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202059.